EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Factors Associated with Hepatitis C Treatment Failure: a Regional Case-Control Study in Kazakhstan

Arailym Maikenova, Alexander V. Nersesov, Aigul Raissova, Elmira Kuantay, Malika Aznabakiyeva, Aisulu Gainutdin, Nazugum Ashimova

Journal of Clinical Medicine of Kazakhstan · 29.10.2026 · 23 (5) · 76-80

DOI: 10.23950/jcmk/19688 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Journal of Clinical Medicine of Kazakhstan, erschienen am 29.10.2026. Verfasst von Arailym Maikenova und 6 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Direct-acting antiviral therapy achieves high cure rates in chronic hepatitis C; however, a minority of patients do not achieve a sustained virologic response. The aim of this study was to evaluate clinical, demographic, and virologic factors associated with failure to achieve a sustained virologic response among patients with chronic hepatitis C treated in the Turkestan Region of Kazakhstan.

Methods

We performed a retrospective case-control study of 168 adults treated with direct-acting antivirals between January 2018 and December 2022. The control group comprised 126 patients who achieved a sustained virologic response, and the case group comprised 42 patients without a sustained virologic response. Demographic characteristics, disease duration, treatment duration, adherence, hepatitis C virus genotype, pretreatment alanine aminotransferase level, liver elastography, and fibrosis stage were analyzed.

Results

Patients without a sustained virologic response had higher pretreatment alanine aminotransferase levels (p=0.03), higher liver stiffness values on elastography (p=0.007), and a longer duration of chronic hepatitis C before treatment (p<0.0001). Genotype 3 was more frequent among cases than controls (59.5% vs 24.6%; p<0.0001), and F4 fibrosis was also more common (40.5% vs 10.3%; p<0.0001). Treatment duration greater than 12 weeks (p=0.02) and lower treatment adherence (p<0.0001) were more frequent in the case group. Age, sex, ethnicity, and previous pegylated interferon/ribavirin therapy did not differ significantly between groups.

Conclusion

Failure to achieve a sustained virologic response was associated with greater biochemical activity, more advanced liver fibrosis, longer disease duration, genotype 3 infection, and lower treatment adherence. Adherence represents a potentially modifiable factor that may be addressed through structured follow-up and patient counseling.

Zitieren

APA

Maikenova, A., Nersesov, A. V., Raissova, A., Kuantay, E., Aznabakiyeva, M., Gainutdin, A., & Ashimova, N. (2026). Factors Associated with Hepatitis C Treatment Failure: a Regional Case-Control Study in Kazakhstan. Journal of Clinical Medicine of Kazakhstan, 23(5), 76-80. https://doi.org/10.23950/jcmk/19688

Vancouver

Maikenova A, Nersesov AV, Raissova A, Kuantay E, Aznabakiyeva M, Gainutdin A, et al. Factors Associated with Hepatitis C Treatment Failure: a Regional Case-Control Study in Kazakhstan. Journal of Clinical Medicine of Kazakhstan. 2026;23(5):76-80. doi:10.23950/jcmk/19688

BibTeX
@article{Maikenova2026,
  author = {Maikenova, Arailym and Nersesov, Alexander V. and Raissova, Aigul and Kuantay, Elmira and Aznabakiyeva, Malika and Gainutdin, Aisulu and Ashimova, Nazugum},
  title = {Factors Associated with Hepatitis C Treatment Failure: a Regional Case-Control Study in Kazakhstan},
  journal = {Journal of Clinical Medicine of Kazakhstan},
  year = {2026},
  volume = {23},
  number = {5},
  pages = {76--80},
  doi = {10.23950/jcmk/19688}
}
Kostenlos starten →